Studies on tumour active compounds


New anticancer drugs and synergism from drug combinations.


Associate Professor Fazlul Huq

Research Location

Cumberland - School of Medical Sciences

Program Type



This project aims to synthesize new metal-based anticancer drugs with activity profile different from cisplatin and its analogues. The project also aims to investigate synergism from combination of drugs including tumour active phytochemicals to provide a means of overcoming drug resistance. Proteomics are employed to characterize key proteins associated with drug resistance.

Additional Information

Currently there are seven PhD students in the group. There has been 14 PhD and 5 Master completions.

Want to find out more?

Contact us to find out what’s involved in applying for a PhD. Domestic students and International students

Contact Research Expert to find out more about participating in this opportunity.

Browse for other opportunities within the Cumberland - School of Medical Sciences .


Ovarian Cancer, drug resistance, synergism, Cisplatin, rule-breaker platinum, Therapeutics & adverse drug effects, Cancer & leukaemia, Cell biology, Pharmacology & therapeutics

Opportunity ID

The opportunity ID for this research opportunity is: 44